An international team of scientists led by Peter Mac has identified a new way to potentially stop cancer cells hiding from the immune system. Their research has identified a master regulator of a protein (PD-L1) which is over-expressed by tumour cells, and which suppresses the immune response to these rogue cancer cells allowing them to proliferate.
Katie Fennell is a PhD student in Peter Mac’s Cancer Epigenetics Lab, led by Professor Mark Dawson. She’s one of the many talented students working at Peter Mac to break new ground in cancer research. To mark National Science Week, she shared why she chose a career in science and what she loves about working at Peter Mac.
Research led by Peter Mac has found a way to map, in unprecedented detail, all of a drug’s clinically important interactions in the body. The new tools can reveal how a small-molecule drug works at the cellular or genetic level, providing scientists with powerful new insights into what drives or - importantly - limits its anti-cancer effect.
Peter Mac's Professor Mark Dawson has been selected as a Howard Hughes Medical Institute (HHMI) International Research Scholar. The scholarship recognises Prof Dawson as a leading early-career scientist working outside of the G7 group of countries.
12,000+ Australians diagnosed with blood cancers each year could soon have access to a simple blood test to monitor their disease thanks to a world-first ‘liquid biopsy’ developed at Peter MacCallum Cancer Centre.
Peter MacCallum Cancer Centre, in collaboration with the VCCC alliance and other partners, has been generously awarded $1.5 million to accelerate research into improved treatments for Chronic Lymphocytic Leukaemia (CLL).
The Peter MacCallum Cancer Centre acknowledges the traditional
owners of the land on which our five sites are located throughout Victoria.
We recognise their strength and resilience and pay our respects
to their Elders past and present.